allogeneic off the shelf NK cell therapy (Alphageneron Pharmaceuticals)

N/A

Report date: 2025/03/14 16:24:13

Base Information

Drug Nameallogeneic off the shelf NK cell therapy (Alphageneron Pharmaceuticals)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cells stimulantsImmunostimulants
TargetsUpdating
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlphageneron Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlphageneron Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A